Learn More
Invitrogen™ CHD9 Polyclonal Antibody

Description
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. Immunogen sequence: SLRSQQNRNN LNPGQNSLSQ SKNFMNVSGP HRVNVNHPPQ MTNASNSQQS ISMQQFSQTS NPSAHFHKCS SHQEGNFNGP SPNMTSCSVS NSQQFSSHYS FSSNHISPNS LLQSSA Highest antigen sequence indentity to the following orthologs: Mouse - 72%, Rat - 69%.
Specifications
Specifications
| Antigen | CHD9 |
| Applications | Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.05 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | Chd9 |
| Gene Accession No. | Q3L8U1 |
| Gene Alias | 1810014J18Rik; 9030205D12Rik; A330063D19Rik; AD013; AD-013; ATP-dependent helicase CHD9; BC022889; Chd9; CHD-9; chromatin remodeling factor CHROM1; chromatin-related mesenchymal modulator; Chromatin-remodeling factor CHROM1; chromodomain helicase DNA binding protein 9; chromodomain-helicase-DNA-binding protein 9; ciprofibrate bound protein p240; ciprofibrate-bound protein PRIC320; CReMM; FLJ12178; Kiaa0308; KISH2; Kismet homolog 2; mKIAA0308; peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein; PPAR{gamma}-interacting cofactor 320 kDa; PPAR-alpha-interacting complex protein 320 kDa; PRIC320; proteinx0008; x0008 |
| Gene Symbols | Chd9 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.